Latest newsNews About usAbliva Latest newsCompany calendar DevelopmentPrimary mitochondrial diseasesPrimary mitochondrial diseases are metabolic diseases that affect the cells’ abili to convert energy. The disorders can manifest differently depending on the organs affected and have historically been viewed as clinical syndromes, Investor relationsInvestorsAbliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell’s energy provider, the mitochondria, do not function properly. The company is focused on two projects. Our team Events and Presentations Contact Our partners and advisers General meeting Financial Calendar PresentationsUpcoming eventsKvinnokvällen (Women’s night) Malmö, and BioStock Life Science SummitRead more